Updated:
Original:

Biotech’s new money is out in force at JP Morgan 2016 (and why it will be there in 2026)

It’s not dumb money. They are seeing things differently.

Related

A deeper understanding of corporate venture capital in healthcare (finally!)

It’s time to know more about corporate venture capital because, unlike traditional venture or angel groups, there’s much less insight on corporate VCs and their practices.

Litigation Finance Firms: Clients Tell Us About The Players That Matter

Check out some findings from the first-ever survey of client experiences with litigation finance firms here!

Silicon Valley Is A Paradigm For Litigation Finance

If only the Pied Piper boys had known about litigation finance.